tobramycin treatment infect due pseudomona aeruginosa patient cystic fibrosi effect safeti tobramycin infect due pseudomona aeruginosa patient cystic fibrosi studi 15 patient moderatetosever exacerb chronic pulmonari infect seventeen cours treatment given tobramycin 575 mgkg per day wa administ intraven three divid dose per day seven 21 day specimen sputum yield moderatetoheavi growth p aeruginosa isol inhibit 4 mug tobramycinml seven case isol inhibit 4 mug gentamicinml mean level tobramycin blood 44 mugml 051 hr 08 mugml 758 hr administr patient receiv antistaphylococc agent befor dure therapi patient except two receiv 750 mg carbenicillinkg per day intraven six divid dose 1 g carbenicillin mask inhal three time day clinic radiolog improv wa note patient white blood cell count wa elev seven patient return normal level blood gase improv p aeruginosa wa elimin sputum five case advers side effect note